Revisiting Rose: strategies for reducing coronary heart disease - Wikidata - awgldk - TriplyDB

Revisiting Rose: strategies for reducing coronary heart disease

Revisiting Rose: strategies for reducing coronary heart disease

http://www.wikidata.org/entity/Q34452615

about

Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang Will cardiovascular disease prevention widen health inequalities?A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study.Cardiovascular Disease Population Risk Tool (CVDPoRT): predictive algorithm for assessing CVD risk in the community setting. A study protocol.The cardio-protective diet.Effectiveness of community-wide and individual high-risk strategies to prevent diabetes: a modelling study.Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP).Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study.Predictive genetic testing for the identification of high-risk groups: a simulation study on the impact of predictive ability.Predicting Stroke Risk Based on Health Behaviours: Development of the Stroke Population Risk Tool (SPoRT)White coat hypertension is more risky than prehypertension: important role of arterial wave reflections Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program.Families of patients with premature coronary heart disease: an obvious but neglected target for primary prevention.Which population groups should be targeted for cardiovascular prevention? A modelling study based on the Norwegian Hordaland Health Study (HUSK).Measuring Burden of Unhealthy Behaviours Using a Multivariable Predictive Approach: Life Expectancy Lost in Canada Attributable to Smoking, Alcohol, Physical Inactivity, and Diet.Hypertension control in industrial employees: findings from SHIMSCO study Can measurement of B-type natriuretic peptide levels improve cardiovascular disease prevention?The 2006 Canadian dyslipidemia guidelines will prevent more deaths while treating fewer people--but should they be further modified?Population health: challenges for science and society.The relative merits of population-based and targeted prevention strategies Modeling the impact of prevention policies on future diabetes prevalence in the United States: 2010-2030.Temporal shifts in cardiovascular risk factor distribution.Patient satisfaction with doctor-patient interaction and its association with modifiable cardiovascular risk factors among moderately-high risk patients in primary healthcare.An analysis of the management of cardiovascular risk factors in routine clinical practice in Italy: an overview of the main findings of the EFFECTUS study.The increasing burden of hypertension in Nigeria - can a dietary salt reduction strategy change the trend?Modes of delivery in preventive intervention studies: a rapid review.Review on cardiovascular risk prediction.Integrated preclinical cardiovascular prevention: a new paradigm to face growing challenges of cardiovascular disease.Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?Validation of a population coronary disease predictive system: the CASSANDRA model.Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database.Implementation of a comprehensive intervention for patients at high risk of cardiovascular disease in rural China: A pragmatic cluster randomized controlled trial Prevalence of 'borderline' values of cardiovascular risk factors in the clinical practice of general medicine in Italy: results of the BORDERLINE study.Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in China.Statin prescribing according to gender, age and indication: what about the benefit-risk balance?Sick Populations and Sick Subpopulations: Reducing Disparities in Cardiovascular Disease Between Blacks and Whites in the United States Coronary heart disease and risk for cognitive impairment or dementia: Systematic review and meta-analysis.

P2860

Q24658434-1187A0CE-8177-424A-BD53-E93AB3994C1D Q33588766-1B728F44-82A4-43C3-8ED8-06A0E54BAA15 Q33682023-A78B4B53-59D1-460A-B8A8-CD9FF37D8F8F Q34116368-05643F68-AC76-4F23-BE8E-0E67ED39C9CB Q34366183-9A1F51E5-62BF-49EF-B737-2E0B66650933 Q34397159-EBFBB4DF-FB0D-442B-AEC2-A31158C812E3 Q34530038-C52A4176-00D8-4A3F-9F18-DCE00B72E093 Q34544605-3BEB3CB3-1AE5-4648-8F65-F6F0C16F3EFE Q34555488-87224F0D-2291-469B-82D2-2D83BDB06EE5 Q35356996-D2DC46B8-1D87-4922-B041-B67AA995E4DA Q35565720-B37ABC5A-05CA-4CA7-B439-D364F9528D85 Q35861221-52CA010E-57E9-41CB-86B8-A98323E09648 Q35954805-398B9163-D750-482A-8315-B2A0A01789BA Q35964467-DE68783F-5D69-4490-A7F1-675EFBD1D6D6 Q35980989-514B3AAE-76BC-4641-8AFA-D9CF2F9BC722 Q36047855-AEA706B9-71A4-4B67-B2F0-29668D08A6E0 Q36105034-5459352E-1F47-483D-8EB6-A15C22D4823D Q36144658-E1034107-6257-4C17-A93E-124E238E01F8 Q37097127-422B18CD-A6B6-4B87-9B57-280158940AB0 Q37101445-C34AEA19-D811-4F18-9B7F-6174343C8FBC Q37212063-39B7FA87-A6C7-4921-948E-949C1191DBAF Q37212186-40D137FD-1F97-4C0B-AC52-B518338BC41C Q37368036-CC9520A8-F380-4A64-B7C9-EF69904060D7 Q37504533-D7F1CF4E-8E3F-4E4A-88EF-EF3E5869C6E9 Q37661718-6508E123-4F81-40A7-A6CB-7A56F4589FA3 Q37879657-34FB4547-4D28-4B99-A41A-C1316A37A664 Q38134047-E6A205B3-97CD-431A-B520-BA99F2C0B8B6 Q38211807-48117AE1-F4E9-4050-9446-B5C35CCD4C60 Q38373055-488B2E86-49F6-42B1-8ECF-9276938C464D Q38430611-0A9520E0-7F99-442E-BC12-8321C360AC25 Q38492555-CF5290D5-229A-47A8-B505-D72D3A93748E Q38770466-C7C42AC1-D248-42DE-94EC-480BAFB4664D Q39233353-569D63CA-BA0D-4D7C-A58F-F5E64EF75923 Q39389575-F74F0001-C7F9-4841-A4E5-17DCF2E5B86C Q39584391-AE650C30-1354-40AF-BBDE-8411103B5C41 Q39722466-4B891AC9-0A20-40C7-83B3-772A3A723AE2 Q39875044-B1B603A3-17A8-4CC2-98B5-C521981368CD Q40455288-43D00F07-014E-4765-8C6E-83DAD5D39A66 Q40690821-D9DF8FA4-AF71-4DDC-9FBF-9190EA00ED09 Q41493209-FE6477AE-7CCD-4B9F-AB02-4F8296B4549F

P2860

Revisiting Rose: strategies for reducing coronary heart disease

http://www.wikidata.org/entity/Q34452615

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Revisiting Rose: strategies for reducing coronary heart disease

@ast

Revisiting Rose: strategies for reducing coronary heart disease

@en

Revisiting Rose: strategies for reducing coronary heart disease

@nl

type

label

Revisiting Rose: strategies for reducing coronary heart disease

@ast

Revisiting Rose: strategies for reducing coronary heart disease

@en

Revisiting Rose: strategies for reducing coronary heart disease

@nl

prefLabel

Revisiting Rose: strategies for reducing coronary heart disease

@ast

Revisiting Rose: strategies for reducing coronary heart disease

@en

Revisiting Rose: strategies for reducing coronary heart disease

@nl

P1433

Q34452615-63BD9439-7F94-469D-900A-8A0B328574B9

P1476

Q34452615-896BA509-D739-4F09-A18E-C047FEAFD04B

P2093

Q34452615-2D78FB38-37E9-4212-B738-85F3F0A97ECB

Q34452615-66E1E88F-9493-4E72-9900-E93439CE1079

Q34452615-7BA512D1-D9C2-4940-A17D-271AC35598B3

Q34452615-858FE4BA-76DC-4A84-86A8-5E1194EE2C2E

Q34452615-AE21C2DA-82FD-42D3-8DBA-B37EDB1AE2A6

Q34452615-C125E6BD-F155-42F5-B2BB-FA8FC34BAF01

Q34452615-D3B7CA65-9B65-4E83-9DED-E1B6BE172A94

P2860

Q34452615-0AB36842-1860-4562-B6D2-4BAAD972188D

Q34452615-3518F1C5-4850-42E0-8596-9B5C6DF3E1CE

Q34452615-4CA034C0-6B40-4179-9F02-0A0599AB31AA

Q34452615-56551F9A-9595-47BB-B18B-DA5BAD41BBCF

Q34452615-62A17875-B991-41BB-ADFE-C06321638B7E

Q34452615-69AC4783-9563-4C2C-B95E-EC97FC3566CF

Q34452615-8239A1D6-D538-4498-948D-D58E7834C754

Q34452615-8EA4B11E-FFD4-49F8-9FA3-643BE1D65152

Q34452615-9E3D4002-1D38-4E26-8376-99555E613F99

Q34452615-B3D831EA-5465-49F2-9C1A-9AD9F8890D86

P304

Q34452615-7CE5EF4F-0DA0-4601-B895-AA2FB2AB6365

P31

Q34452615-6F331E2C-AE39-41C5-BA92-805258695D5A

P356

Q34452615-C99D195A-1FE9-4874-B79F-AA52EC6EC96C

P407

Q34452615-FB44BE8A-0C37-4DDA-9CCB-4E50CE54D63F

P433

Q34452615-2E19BCE9-56AD-4C93-BEFC-B8AFB9F6E138

P478

Q34452615-9BEC1D82-C018-4B40-B092-9BA7215FCFA9

P577

Q34452615-0F8B8DF7-DB8E-44BE-A805-30F623854660

P5875

Q34452615-5788BB47-C397-46FC-8806-18D55927E532

P698

Q34452615-620F9AC2-4E84-4562-A6C6-E1CD9BAA16CA

P932

Q34452615-72618EFA-9C9B-4D88-B9F1-F7A09BC62048

P356

BMJ.332.7542.659

P1433

P1476

Revisiting Rose: strategies for reducing coronary heart disease

@en

P2093

Andreas Laupacis

http://www.w3.org/2001/XMLSchema#string

Cameron A Mustard

http://www.w3.org/2001/XMLSchema#string

David A Alter

http://www.w3.org/2001/XMLSchema#string

Douglas G Manuel

http://www.w3.org/2001/XMLSchema#string

Geoffrey M Anderson

http://www.w3.org/2001/XMLSchema#string

Jenny Lim

http://www.w3.org/2001/XMLSchema#string

Peter Tanuseputro

http://www.w3.org/2001/XMLSchema#string

P2860

Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update

A strategy to reduce cardiovascular disease by more than 80%

Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

Canadian heart health surveys: a profile of cardiovascular risk. Survey methods and data analysis. Canadian Heart Health Surveys Research Group.

A review of five major community-based cardiovascular disease prevention programs. Part II: Intervention strategies, evaluation methods, and results.

Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations.

Long term persistence with statin treatment in daily medical practice.

Sick individuals and sick populations. 1985.

Assessing population-based programs to reduce blood cholesterol level and saturated fats.

P304

659-662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.332.7542.659

http://www.w3.org/2001/XMLSchema#string

P407

P433

7542

http://www.w3.org/2001/XMLSchema#string

P478

332

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7236014

http://www.w3.org/2001/XMLSchema#string

P698

16543339

http://www.w3.org/2001/XMLSchema#string

P932

1403258

http://www.w3.org/2001/XMLSchema#string